{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T01:41:05Z","timestamp":1648863665575},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00059-011-3578-5","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T10:29:14Z","timestamp":1329128954000},"page":"85-96","source":"Crossref","is-referenced-by-count":1,"title":["Konservative Therapie der stabilen koronaren Herzkrankheit"],"prefix":"10.1007","volume":"37","author":[{"given":"F.","family":"Custodis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,4]]},"reference":[{"key":"3578_CR1","unstructured":"Gesundheitsberichterstattung des Bundes, www.gbe-bund.de, Stand 11\/2011"},{"key":"3578_CR2","unstructured":"Nationale Versorgungsleitlinie KHK, Version 1.11, M\u00e4rz 2011, www.khk.versorgungsleitlinien.de"},{"key":"3578_CR3","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","volume":"27","author":"Fox","year":"2006","unstructured":"Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27:1341\u20131381","journal-title":"Eur Heart J"},{"key":"3578_CR4","unstructured":"Arzneimittelkomission der deutschen \u00c4rzteschaft, Empfehlungen zur Prophylaxe und Therapie der stabilen koronaren Herzkrankheit (KHK), www.akdae.de, 1. Auflage, Januar 2004"},{"key":"3578_CR5","doi-asserted-by":"crossref","unstructured":"Gibbons RJ, Abrams J, Chatterjee K et al (2003) ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina \u2013 summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation107:149\u2013158","DOI":"10.1161\/01.CIR.0000047041.66447.29"},{"key":"3578_CR6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00392-003-0960-1","volume":"92","author":"Dietz","year":"2003","unstructured":"Dietz R, Rauch B (2003) Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung (DGK). Z Kardiol 92:501\u2013521","journal-title":"Z Kardiol"},{"key":"3578_CR7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/eurheartj\/ehq297","volume":"32","author":"Laufs","year":"2011","unstructured":"Laufs U, Rettig-Ewen V, B\u00f6hm M (2011) Strategies to improve drug adherence. Eur Heart J 32:264\u2013268","journal-title":"Eur Heart J"},{"key":"3578_CR8","first-page":"CD003041","volume":"1","author":"Critchley","year":"2004","unstructured":"Critchley J, Capewell S (2004) Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 1:CD003041","journal-title":"Cochrane Database Syst Rev"},{"key":"3578_CR9","unstructured":"Arzneimittelkomission der deutschen \u00c4rzteschaft (2010) Therapieempfehlung Tabakabh\u00e4ngigkeit, 2.\u00a0Aufl. www.akdae.de"},{"key":"3578_CR10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMra012586","volume":"346","author":"Yanovski","year":"2002","unstructured":"Yanovski SZ, Yanovski JA (2002) Obesity. N Engl J Med 346:591\u2013602","journal-title":"N Engl J Med"},{"key":"3578_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2007-1024089","volume":"125","author":"Laufs","year":"2000","unstructured":"Laufs U, B\u00f6hm M (2000) The cardiovascular risk factor in obesity. Dtsch Med Wochenschr 125:262\u2013268","journal-title":"Dtsch Med Wochenschr"},{"key":"3578_CR12","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","volume":"124","author":"Smith","year":"2011","unstructured":"Smith SC Jr, Benjamin EJ, Bonow RO et al (2011) AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 124:2458\u20132473","journal-title":"Circulation"},{"key":"3578_CR13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0002-9343(01)01114-7","volume":"112","author":"Bucher","year":"2002","unstructured":"Bucher HC, Hengstler P, Schindler C, Meier G (2002) N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112:298\u2013304","journal-title":"Am J Med"},{"key":"3578_CR14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","volume":"99","author":"de","year":"1999","unstructured":"de Lorgeril M, Salen P, Martin JL et al (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779\u2013785","journal-title":"Circulation"},{"key":"3578_CR15","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.CIR.103.1.e1","volume":"103","author":"Gielen","year":"2001","unstructured":"Gielen S, Schuler G, Hambrecht R (2001) Exercise training in coronary artery disease and coronary vasomotion. Circulation 103:E1\u20136","journal-title":"Circulation"},{"key":"3578_CR16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02892287","volume":"19","author":"Miller","year":"1997","unstructured":"Miller TD, Balady GJ, Fletcher GF (1997) Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Ann Behav Med 19:220\u2013229","journal-title":"Ann Behav Med"},{"key":"3578_CR17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.CIR.102.5.500","volume":"102","author":"Ajani","year":"2000","unstructured":"Ajani UA, Gaziano JM, Lotufo PA et al (2000) Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 102:500\u2013505","journal-title":"Circulation"},{"key":"3578_CR18","first-page":"227","volume":"52","author":"Laufs","year":"2001","unstructured":"Laufs U, B\u00f6hm M (2001) Einfluss von Alkohol auf das kardiovaskul\u00e4re Risiko. Dtsch Z Sportmed 52:227\u2013230","journal-title":"Dtsch Z Sportmed"},{"key":"3578_CR19","unstructured":"Custodis F, Reil J-C, Laufs U, B\u00f6hm M (2010) Herzfrequenzsenkung bei Herzpatienten \u2013 Die Rolle von Ivabradin. Arzneimitteltherapie:294-304"},{"key":"3578_CR20","doi-asserted-by":"crossref","unstructured":"Custodis F, Reil JC, Laufs U, B\u00f6hm M (2011) Herzfrequenz und Frequenzkontrolle. Prognostische Bedeutung bei kardiovaskul\u00e4ren Erkrankungen. Internist, doi 10.1007\/s00108-011-2887-3","DOI":"10.1007\/s00108-011-2887-3"},{"key":"3578_CR21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875\u2013885","journal-title":"Lancet"},{"key":"3578_CR22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","volume":"43","author":"Chaitman","year":"2004","unstructured":"Chaitman BR, Skettino SL, Parker JO et al (2004) Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 43:1375\u20131382","journal-title":"J Am Coll Cardiol"},{"key":"3578_CR23","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","volume":"297","author":"Morrow","year":"2007","unstructured":"Morrow DA, Scirica BM, Karwatowska-Prokopczuk E et al (2007) Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA 297:1775-1783","journal-title":"JAMA"},{"key":"3578_CR24","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143\u20133421","journal-title":"Circulation"},{"key":"3578_CR25","first-page":"2714","volume":"103","author":"Laufs","year":"2006","unstructured":"Laufs U, Hamm C, B\u00f6hm M (2006) Statintherapie bei koronarer Herzkrankheit. Dtsch Arztebl 103:2714\u20132718","journal-title":"Dtsch Arztebl"},{"key":"3578_CR26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"Grundy","year":"2004","unstructured":"Grundy SM, Brewer HB Jr, Cleeman JI et al (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Circulation 109:433\u2013438","journal-title":"Circulation"},{"key":"3578_CR27","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"Reiner","year":"2011","unstructured":"Reiner Z, Catapano AL, De Backer G et al (2011) ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769\u20131818","journal-title":"Eur Heart J"},{"key":"3578_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN et al (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227\u2013239","journal-title":"Circulation"},{"key":"3578_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669\u2013677","journal-title":"N Engl J Med"},{"key":"3578_CR30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS","year":"1987","unstructured":"CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429\u20131435","journal-title":"N Engl J Med"},{"key":"3578_CR31","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa025028","volume":"348","author":"Nichol","year":"2003","unstructured":"Nichol KL, Nordin J, Mullooly J et al (2003) Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 348:1322\u20131332","journal-title":"N Engl J Med"},{"key":"3578_CR32","first-page":"2289","volume":"102","author":"Laufs","year":"2005","unstructured":"Laufs U, B\u00f6hm M (2005) Die Grippeimpfung \u2013 eine kosteneffiziente Prophylaxe der koronaren Herzkrankheit. Dtsch Arztebl 102:2289\u20132292","journal-title":"Dtsch Arztebl"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-011-3578-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-011-3578-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-011-3578-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T10:03:03Z","timestamp":1593684183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-011-3578-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1007\/s00059-011-3578-5","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}